Cargando…

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD

BACKGROUND: Bacterial infections cause approximately 50% of Acute Exacerbations of COPD (AECOPD). Current guidelines recommend a wide range of antibiotics, but evidence comparing agents is limited. The purpose of this study is to compare the effectiveness of azithromycin to beta lactams in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kale-Pradhan, Pramodini, Baalbaki, Nour, Aprilliano, Bianca, Giuliano, Christopher, Hartner, Carrie, Johnson, Leonard B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643851/ http://dx.doi.org/10.1093/ofid/ofab466.1489

Ejemplares similares

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

556. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19
por: Berti, Andrew David, et al.
Publicado: (2020)

Vulnerable COPD patients with comorbidities: the role of roflumilast
por: Lipari, Melissa, et al.
Publicado: (2014)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

2428. Lower Rates of Antibiotic Treatment of Vancomycin-Resistant Compared With Vancomycin Susceptible Enterococcal Bacteriuria
por: Vendittelli, Bridget, et al.
Publicado: (2018)

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

2008. Outcomes of Patients with Positive Procalcitonin Levels Who Do Not Receive Continued Antibiotics
por: George, Jamie, et al.
Publicado: (2019)

49. Clinical Utility of Oseltamivir Restriction Policy
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2020)

1386. Prescribing Patterns of Skin and Soft Tissue Infections in Patients Discharged from the Emergency Department
por: Feist, Jacqueline, et al.
Publicado: (2022)

Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
por: Lieberman, David, et al.
Publicado: (2002)

1469. Effect of Treatment Duration on Outcomes in Septic Patients Admitted for Urinary Tract Infections from Extended Care Facilities
por: Jongekrijg, Annelise, et al.
Publicado: (2019)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Adverse drug reactions in drug information databases: does presentation affect interpretation?
por: McConachie, Sean M., et al.
Publicado: (2020)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
por: Al-Salloum, Jumana, et al.
Publicado: (2021)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023)

1297. In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C, et al.
Publicado: (2020)

Properties of Spontaneous rpsL Mutant of Streptomyces albus KO-1297
por: Shemediuk, A. L., et al.
Publicado: (2022)

Azithromycin: Exacerbation of diaphragm hemiparesis: case report
Publicado: (2020)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

1297. Design and Testing of an Interactive Module for Improving Understanding and Application of Institutional Antibiograms
por: MacDougall, Conan
Publicado: (2022)

1297. Implementation of a Prosthetic Joint Infection Clinic in a Rural Setting
por: Lindsay, John D, et al.
Publicado: (2023)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2023)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN
por: Liang, Limin, et al.
Publicado: (2018)

1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
por: Mathur, Poonam, et al.
Publicado: (2018)

miR-1297 Suppresses Osteosarcoma Proliferation and Aerobic Glycolysis by Regulating PFKFB2
por: Pan, Xiaohui, et al.
Publicado: (2020)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

Beta-lactam allergy in Chinese patients and factors predicting genuine allergy
por: Li, Philip Hei, et al.
Publicado: (2019)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

Beta-lactam hypersensitivity: not always what it seems
por: Andrade, Djanira, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_54pdjtivdvi8v4egp3lnlq84v5